DE2352905A1 - Vom koerper nicht absorbierbare geschmackhervorrufende mittel und verfahren zu ihrer herstellung - Google Patents

Vom koerper nicht absorbierbare geschmackhervorrufende mittel und verfahren zu ihrer herstellung

Info

Publication number
DE2352905A1
DE2352905A1 DE19732352905 DE2352905A DE2352905A1 DE 2352905 A1 DE2352905 A1 DE 2352905A1 DE 19732352905 DE19732352905 DE 19732352905 DE 2352905 A DE2352905 A DE 2352905A DE 2352905 A1 DE2352905 A1 DE 2352905A1
Authority
DE
Germany
Prior art keywords
group
taste
molecule
active
flavor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19732352905
Other languages
German (de)
English (en)
Inventor
Alejandro Zaffaroni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dynapol Corp
Original Assignee
Dynapol Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US300499A external-priority patent/US3876816A/en
Application filed by Dynapol Corp filed Critical Dynapol Corp
Publication of DE2352905A1 publication Critical patent/DE2352905A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/75—Fixation, conservation, or encapsulation of flavouring agents the flavouring agents being bound to a host by chemical, electrical or like forces, e.g. use of precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Seasonings (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19732352905 1972-10-25 1973-10-22 Vom koerper nicht absorbierbare geschmackhervorrufende mittel und verfahren zu ihrer herstellung Withdrawn DE2352905A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30085772A 1972-10-25 1972-10-25
US300499A US3876816A (en) 1972-10-25 1972-10-25 Nonabsorbable, nonnutritive sweeteners

Publications (1)

Publication Number Publication Date
DE2352905A1 true DE2352905A1 (de) 1974-05-09

Family

ID=26971813

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732352905 Withdrawn DE2352905A1 (de) 1972-10-25 1973-10-22 Vom koerper nicht absorbierbare geschmackhervorrufende mittel und verfahren zu ihrer herstellung

Country Status (10)

Country Link
JP (1) JPS5631944B2 (enExample)
CA (1) CA1011986A (enExample)
CH (1) CH591215A5 (enExample)
DE (1) DE2352905A1 (enExample)
FR (1) FR2204369B1 (enExample)
GB (1) GB1423700A (enExample)
IL (1) IL43475A (enExample)
IT (1) IT1047950B (enExample)
NL (1) NL7314587A (enExample)
SU (1) SU508160A3 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2390111B1 (fr) * 1977-01-21 1988-02-19 Polak Frutal Works Procede pour la fixation d'aldehydes aromatisants en vue de leur application dans le domaine alimentaire
US4448789A (en) * 1982-08-27 1984-05-15 Warner-Lambert Company Enhanced flavor-releasing agent
IT1186782B (it) * 1985-10-18 1987-12-16 Montedison Spa Processo per la preparazione di fenilpropanoni
GB0916178D0 (en) * 2009-09-15 2009-10-28 Givaudan Sa Organic compounds

Also Published As

Publication number Publication date
GB1423700A (en) 1976-02-04
IT1047950B (it) 1980-10-20
JPS49100266A (enExample) 1974-09-21
IL43475A0 (en) 1974-01-14
IL43475A (en) 1976-04-30
JPS5631944B2 (enExample) 1981-07-24
CA1011986A (en) 1977-06-14
FR2204369B1 (enExample) 1979-10-19
NL7314587A (enExample) 1974-04-29
AU6144173A (en) 1975-04-17
SU508160A3 (ru) 1976-03-25
FR2204369A1 (enExample) 1974-05-24
CH591215A5 (enExample) 1977-09-15

Similar Documents

Publication Publication Date Title
DE69029006T2 (de) Wasserlösliche hochmolekulare polymere Arzneistoffzubereitung
EP0441468B1 (de) Aus Polyaldehyden aufgebaute gasenthaltende Mikropartikel als Kontrastmittel
DE69625326T2 (de) Anthracyclinderivate und sie enthaldende medizinische zubereitungen
DE69725862T2 (de) Auf polymeren mit hohem molekulargewicht basierende medikamentvorstufen
DE69825619T2 (de) Strikt alternierende poly(alkylenoxid)copolymere
EP1136487B1 (de) Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung als Antirauchmittel
DE60109745T2 (de) Polymere micellenartige struktur
CH638803A5 (de) Verfahren zur herstellung neuer 4-amino-4-arylcyclohexanon-ketale.
EP1476470B1 (de) ST RKEDERIVATE, ST RKE−WIRKSTOFF−KONJ UGATE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS ARZNEIMITTEL
DE1492107A1 (de) Verfahren zur Herstellung einer Tablette
DE3241097A1 (de) Medikamente mit hohem loeslichkeitsgrad und verfahren zu ihrer herstellung
DE69612987T2 (de) Selektiv funktionalisierbare desdendrimere
DE2805928A1 (de) Wasserloesliche, nicht ionische roentgenkontrastmittel und verfahren zu ihrer herstellung
DE60024601T2 (de) Dispergierbare zusammensetzungen von macroliden und verfahren zu deren herstellung
DE3780361T2 (de) Gastroprotektives verfahren und zusammensetzungen.
DE2427938A1 (de) Ionenpolymere und verfahren zu ihrer herstellung
DE2756216A1 (de) Phenylalkylhydroxamsaeuren, ihre herstellung und verwendung in arzneimitteln
DE2352905A1 (de) Vom koerper nicht absorbierbare geschmackhervorrufende mittel und verfahren zu ihrer herstellung
CH644874A5 (de) Copolymere aus olefinen und alpha,beta-ungesaettigten polycarbonsaeureanhydriden, verfahren zu ihrer herstellung und ihre verwendung.
DE1965431A1 (de) Inosin-Komplexverbindungen
DE2830901C2 (de) Reaktionsprodukte von Methotrexat und Divinyläther-Maleinsäureanhydrid- copolymerisaten, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2032914A1 (enExample)
CH643862A5 (de) Bis(4-demethoxydaunorubicin)dihydrazon-derivate und sie enthaltende pharmazeutische zubereitungen.
DE1617743C3 (de) Röntgenkontrastmittel
CH630895A5 (de) Verfahren zur herstellung neuer oximaetherverbindungen.

Legal Events

Date Code Title Description
OD Request for examination
8130 Withdrawal